SEC Form 4 · accession 0001385508-18-000071
OPIANT PHARMACEUTICALS, INC. · OPNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David D O'Toole
Officer — Chief Financial Officer
Period of report
Aug 14, 2018
Accepted (ET)
Aug 14, 2018 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001385508
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 14, 2018 | P | 15 | $16.40 | A | 5,015 | D | |
| Common Stock | Aug 14, 2018 | P | 1,000 | $15.39 | A | 6,015 | D |
Table II — derivative securities
No Table II lines on this filing.